StructoKabiven Infusionsvätska, emulsion Thụy Điển - Tiếng Thụy Điển - Läkemedelsverket (Medical Products Agency)

structokabiven infusionsvätska, emulsion

fresenius kabi ab - alanin; arginin; fenylalanin; glukosmonohydrat; glycin; histidin; isoleucin; kalciumkloriddihydrat; kaliumklorid; leucin; lysinacetat; magnesiumsulfatheptahydrat; metionin; natriumacetattrihydrat; natriumglycerofosfat, vattenfritt; prolin; renad strukturerad triglycerid; serin; taurin; treonin; tryptofan; tyrosin; valin; zinksulfatheptahydrat - infusionsvätska, emulsion - fenylalanin 5,1 mg aktiv substans; prolin 11,2 mg aktiv substans; serin 6,5 mg aktiv substans; taurin 1 mg aktiv substans; treonin 4,4 mg aktiv substans; tryptofan 2 mg aktiv substans; tyrosin 0,4 mg aktiv substans; valin 6,2 mg aktiv substans; kalciumkloriddihydrat 0,74 mg aktiv substans; natriumglycerofosfat, vattenfritt 4,2 mg aktiv substans; magnesiumsulfatheptahydrat 2,47 mg aktiv substans; kaliumklorid 4,48 mg aktiv substans; natriumacetattrihydrat 5,62 mg aktiv substans; zinksulfatheptahydrat 23 mikrog aktiv substans; renad strukturerad triglycerid 200 mg aktiv substans; glycerol hjälpämne; metionin 4,3 mg aktiv substans; lysinacetat 9,3 mg aktiv substans; leucin 7,4 mg aktiv substans; isoleucin 5 mg aktiv substans; histidin 3 mg aktiv substans; glycin 11 mg aktiv substans; arginin 12 mg aktiv substans; alanin 14 mg aktiv substans; glukosmonohydrat 462 mg aktiv substans - kombinationer

StructoKabiven Elektrolytfri Infusionsvätska, emulsion Thụy Điển - Tiếng Thụy Điển - Läkemedelsverket (Medical Products Agency)

structokabiven elektrolytfri infusionsvätska, emulsion

fresenius kabi ab - alanin; arginin; fenylalanin; glukosmonohydrat; glycin; histidin; isoleucin; leucin; lysinacetat; metionin; prolin; renad strukturerad triglycerid; serin; taurin; treonin; tryptofan; tyrosin; valin - infusionsvätska, emulsion - renad strukturerad triglycerid 200 mg aktiv substans; valin 6,2 mg aktiv substans; tyrosin 0,4 mg aktiv substans; tryptofan 2 mg aktiv substans; treonin 4,4 mg aktiv substans; taurin 1 mg aktiv substans; serin 6,5 mg aktiv substans; prolin 11,2 mg aktiv substans; fenylalanin 5,1 mg aktiv substans; metionin 4,3 mg aktiv substans; lysinacetat 9,3 mg aktiv substans; leucin 7,4 mg aktiv substans; isoleucin 5 mg aktiv substans; histidin 3 mg aktiv substans; glycin 11 mg aktiv substans; arginin 12 mg aktiv substans; alanin 14 mg aktiv substans; glukosmonohydrat 462 mg aktiv substans; glycerol hjälpämne - kombinationer

StructoKabiven Perifer Infusionsvätska, emulsion Thụy Điển - Tiếng Thụy Điển - Läkemedelsverket (Medical Products Agency)

structokabiven perifer infusionsvätska, emulsion

fresenius kabi ab - alanin; arginin; fenylalanin; glukosmonohydrat; glycin; histidin; isoleucin; kalciumkloriddihydrat; kaliumklorid; leucin; lysinacetat; magnesiumsulfatheptahydrat; metionin; natriumacetattrihydrat; natriumglycerofosfat, vattenfritt; prolin; renad strukturerad triglycerid; serin; taurin; treonin; tryptofan; tyrosin; valin; zinksulfatheptahydrat - infusionsvätska, emulsion - taurin 1 mg aktiv substans; treonin 4,4 mg aktiv substans; tryptofan 2 mg aktiv substans; tyrosin 0,4 mg aktiv substans; valin 6,2 mg aktiv substans; kalciumkloriddihydrat 0,74 mg aktiv substans; natriumglycerofosfat, vattenfritt 4,18 mg aktiv substans; magnesiumsulfatheptahydrat 2,47 mg aktiv substans; kaliumklorid 4,48 mg aktiv substans; natriumacetattrihydrat 5,62 mg aktiv substans; zinksulfatheptahydrat 23 mikrog aktiv substans; serin 6,5 mg aktiv substans; prolin 11,2 mg aktiv substans; fenylalanin 5,1 mg aktiv substans; metionin 4,3 mg aktiv substans; lysinacetat 9,3 mg aktiv substans; leucin 7,4 mg aktiv substans; isoleucin 5 mg aktiv substans; histidin 3 mg aktiv substans; glycin 11 mg aktiv substans; arginin 12 mg aktiv substans; alanin 14 mg aktiv substans; glukosmonohydrat 143 mg aktiv substans; renad strukturerad triglycerid 200 mg aktiv substans; glycerol hjälpämne - kombinationer

Comirnaty Liên Minh Châu Âu - Tiếng Thụy Điển - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. användning av detta vaccin bör ske i enlighet med officiella rekommendationer.

Spikevax (previously COVID-19 Vaccine Moderna) Liên Minh Châu Âu - Tiếng Thụy Điển - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Vedrop Liên Minh Châu Âu - Tiếng Thụy Điển - EMA (European Medicines Agency)

vedrop

recordati rare diseases - tokofersolan - cholestasis; vitamin e deficiency - vitaminer - vedrop är indicerat i-e-vitaminbrist på grund av mag malabsorption i pediatriska patienter som lider av medfödd kronisk kolestas eller ärftlig kronisk kolestas, från födseln (i termen nyfödda) till 16 eller 18 år, beroende på region.

Lopid 300 mg Kapsel, hård Thụy Điển - Tiếng Thụy Điển - Läkemedelsverket (Medical Products Agency)

lopid 300 mg kapsel, hård

pfizer ab - gemfibrozil - kapsel, hård - 300 mg - propylenglykol hjälpämne; gemfibrozil 300 mg aktiv substans - gemfibrozil

Lopid 300 mg Kapsel, hård Thụy Điển - Tiếng Thụy Điển - Läkemedelsverket (Medical Products Agency)

lopid 300 mg kapsel, hård

omnia läkemedel ab - gemfibrozil - kapsel, hård - 300 mg - gemfibrozil 300 mg aktiv substans - gemfibrozil

Lopid 300 mg Kapsel, hård Thụy Điển - Tiếng Thụy Điển - Läkemedelsverket (Medical Products Agency)

lopid 300 mg kapsel, hård

orifarm ab - gemfibrozil - kapsel, hård - 300 mg - gemfibrozil 300 mg aktiv substans - gemfibrozil

Lopid 450 mg Filmdragerad tablett Thụy Điển - Tiếng Thụy Điển - Läkemedelsverket (Medical Products Agency)

lopid 450 mg filmdragerad tablett

pfizer ab - gemfibrozil - filmdragerad tablett - 450 mg - gemfibrozil 450 mg aktiv substans - gemfibrozil